Cytomegalovirus Localization in Atherosclerotic Plaques is Associated with Acute Coronary Syndromes: Report of 105 Patients

It has been shown that cytomegalovirus (CMV) is present in coronary atherosclerotic plaques, but the clinical rele-vance of this presence remains to be elucidated. In this study we sought to examine CMV infection in atherosclerosis patients defined by different methods and to identify the clinical significance of CMV replication in the atherosclerotic plaques. The study included 105 consecutive patients who were admitted to our department and underwent coronary artery bypass grafting (CABG) surgical interventions. Coronary atherosclerotic specimens as well as 53 specimens from the mamillary artery of these same patients were analyzed. Enzyme-linked immunosorbent assay (ELISA) and poly-merase chain reaction (PCR) methods were used for evaluations. The CMV PCR test result was positive for 28 (26.7%) of patients with coronary artery atherosclerosis. After adjusting for other risk factors, coronary artery disease patients with a history of acute coronary syndrome were more likely to be positive for CMV PCR test (P=0.027; odds ratio: 4.2; 95% CI: 1.18-15.0). They were also more likely to have a positive family history for cardiovascular diseases (CVD). This study confirms previous evidence about the replication of CMV virus in the atherosclerotic plaques of coronary arteries and brings clinical significance to this observation by showing a higher prevalence of acute coronary syndromes in those patients with CMV-infected plaques. Our study also suggests a familial vulnerability to CMV replication in the coronary artery walls.     

Parameter optimization and degradation mechanism for electrocatalytic degradation of 2,4-diclorophenoxyacetic acid (2,4-D) herbicide by lead dioxide electrodes

2,4-Dichlorophenoxyacetic acid (2,4-D) is one of the most commonly used herbicides in the world. In this work, the electro-catalytic degradation of 2,4-D herbicide from aqueous solutions was evaluated using three anode electrodes, i.e., lead dioxide coated on stainless steel 316 (SS316/β-PbO₂), lead dioxide coated on a lead bed (Pb/β-PbO₂), and lead dioxide coated on graphite (G/β-PbO₂). The structure and morphology of the prepared electrodes were studied by X-ray diffraction (XRD), scanning electron microscopy (SEM) and energy dispersive X-ray spectroscopy (EDX). The process of herbicide degradation was monitored during constant current electrolysis using cyclic voltammetry (CV). In this study, the experiments were designed based on the central composite design (CCD) and were analyzed and modeled by response surface methodology (RSM) to demonstrate the operational variables and the interactive effect of three independent variables on 3 responses. The effects of parameters including pH (3–11), current density (j = 1–5 mA cm⁻²) and electrolysis time (20–80 min) were studied. The results showed that, at j = 5 mA cm⁻², by increasing the reaction time from 20 to 80 min and decreasing the pH from 11 to 3, the 2,4-D herbicide degradation efficiency using SS316/β-PbO₂, Pb/β-PbO₂ and G/β-PbO₂ anode electrodes was observed to be 60.4, 75.9 and 89.8%, respectively. Moreover, the results showed that the highest COD and TOC removal efficiencies using the G/β-PbO₂ electrode were 83.7 and 78.5%, under the conditions pH = 3, electrolysis time = 80 min and j = 5 mA cm⁻², respectively. It was also found that G/β-PbO₂ has lower energy consumption (EC) (5.67 kW h m⁻³) compared to the two other studied electrodes (SS316/β-PbO₂ and Pb/β-PbO₂). The results showed a good correlation between the experimental values and the predicted values of the quadratic model (P < 0.05). Results revealed that the electrochemical process using the G/β-PbO₂ anode electrode has an acceptable efficiency in the degradation of 2,4-D herbicide and can be used as a proper pretreatment technique to treat wastewater containing resistant pollutants, e.g., phenoxy group herbicides (2,4-D).

Optimization of process parameters by the CCD method and electrocatalytic degradation and the electrochemical degradation mechanism of 2,4-D using modified electrode anodes were investigated.     

Hepatitis B virus genotypes in southwest Iran： Molecular, serological and clinical outcomes

AIM： To investigate the associations of hepatitis B virus （HBV） genotype with HBeAg and anti-HBe status, alanine aminotransferase （ALT） levels and HBV-DNA detection in different groups of HBV-infected patients in southwest Iran. METHODS： A total of 89 HBsAg-positive serum samples were collected from the same number of patients. All sera were then investigated to determine HBV DNA and serological markers. For all the polymerase chain reaction （PCR）-positive samples, biochemical, histopathological assays and genotyping were also performed. RESULTS： Genotype D was the only type of HBV foundin different clinical forms of acute and chronic infections. There was a high prevalence of HBeAg-negative HBV- infected patients with chronic hepatitis （52.7%）. Out of 55 patients with chronic hepatitis, seven （12.7%） were diagnosed with cirrhosis. A significant association between the presence of anti-HBe antibody and an increase in ALT level, among either HBeAg-negative （P = 0.01） or HBeAg-positive （P = 0.026） patients, was demonstrated. No significant differences were observed between the clinical outcomes of HBeAg-positive and -negative individuals （P = 0.24）. CONCLUSION： Genotype D has been recognized as the only type of HBV found in different clinical forms of HBV infections, including cirrhosis, among the residents of southwest Iran. Anti-HBe possibly plays a role in disease progression in some patients with chronic hepatitis, at least for a period of disease.     

A 10-Year Cardiovascular Risk in Adults with Different Levels of Spiritual Health: Tehran Lipid and Glucose Study

Background:Previous studies have shown that spiritual experience may reduce cardiovascular disease (CVDs). However, little is known about the relationship between spiritual health and the gender-specific risk of CVDs in communities with different cultures.Methods:A total of 3249 individuals (53.7% female, 75.0% middle-aged) participated in the Tehran Lipid and Glucose Study (TLGS) from 2015 to 2017 were included. Based on the ACC/AHA pooled cohort equation, CVD risk over ten years was examined. Spiritual health was measured using a developed tool for measuring spiritual health in Muslim populations (SHIMA-48). Linear regression models were used to assess the association between spiritual health and ACC/AHA risk scores. The natural logarithm scale was calculated to consider the normal distribution hypothesis of the regression model.Results:The current results suggest a slight but significant increase in the mean of spiritual health in women compared to men in both cognitive/emotional and behavioral dimensions (P < 0.001). In both sexes, a higher prevalence of smoking was observed in participants with lower levels of spiritual health (P < 0.004). In men, compared to those with a low level of spiritual health (the first tertile), the logarithm of the ACC-AHA risk score was reduced by 0.11 (P = 0.004) and 0.18 (P < 0.001) for those in the second and third tertiles of spiritual health, respectively. This result may be attributed to higher cigarette smoking among the latter group. Similar results were not observed in women.Conclusions:Current results indicate a gender-specific association between spiritual health and cardiovascular disease risk. Our findings imply that promoting spiritual health can be considered an effective strategy in future preventive interventions, primarily by controlling the desire to smoke in men.